Vertex's hepatitis C drug Incivek gains Canadian approval

08/22/2011 | Fox Business

Health Canada approved Incivek, Vertex Pharmaceuticals' treatment for genotype 1 hepatitis C in patients with compensated liver disease. Incivek, taken with ribavirin and pegylated interferon, was clinically proven to achieve a higher viral-cure rate than standard therapy.

View Full Article in:

Fox Business

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX